STAT+: Pharmalittle: J&J Covid-19 vaccine production is behind schedule; Slaoui resigns from Operation Warp Speed
Rise and shine, everyone, the middle of the week is already here, which means we have managed to survive this far. And this calls for celebration, yes? So please join us as we hoist another cup of delicious stimulation — our choice today is mountain blueberry. Remember, no prescription is required, so no need to calculate a rebate. Meanwhile, here are a few items of interest. Have a grand day, and drop us a line if you hear something saucy. …
Johnson & Johnson (JNJ) expects to release results from its Covid-19 vaccine trial in as little as two weeks, but unanticipated manufacturing delays will prevent the vaccine from getting out the door and into arms until April, The New York Times reports. Federal officials have been told that the company has fallen as much as two months behind the original production schedule and will not catch up until the end of April, when it was supposed to have delivered more than 60 million doses of the single-shot vaccine.
Continue to STAT+ to read the full story…
